M&A

Vertex expects more, perhaps bigger M&A to come
Biopharma Dive
Fri, 08/2/19 - 12:14 am
Vertex Pharmaceuticals
M&A
GSK split edges closer as OTC joint venture deal with Pfizer closes
Pharmaforum
Thu, 08/1/19 - 11:48 am
GSK
Pfizer
OTC
M&A
Megadeals aside, pharma M&A actually dropped in the first half of 2019: report
Fierce Pharma
Wed, 07/31/19 - 10:37 am
M&A
Novartis' $18.5B in M&A under Vas Narasimhan says a lot about their careful — but opportunistic — deal strategy
Endpoints
Wed, 07/31/19 - 10:24 am
Novartis
Vas Narasimhan
M&A
Pharma CEOs
Celgene Offers Beat-And-Raise As Bristol Merger Looms Closer
Investors Business Daily
Wed, 07/31/19 - 08:50 am
Celgene
earnings
M&A
Bristol-Myers Squibb
Gilead's exec search won't hurt its deal search: CEO
Fierce Pharma
Wed, 07/31/19 - 08:46 am
Gilead Sciences
M&A
Daniel O'Day
How Mylan ended as a junior partner in its Pfizer deal
Biopharma Dive
Tue, 07/30/19 - 04:20 pm
Mylan
Pfizer
Perrigo
Teva Pharmaceutical
M&A
NEC buys OncoImmunity to boost AI-based cancer research
Pharmaforum
Tue, 07/30/19 - 08:04 am
NEC
M&A
OncoImmunity
artificial intelligence
machine learnings
R&D
cancer
With Mylan deal, Pfizer seeks faster growth via innovation focus
BioCentury
Mon, 07/29/19 - 11:23 pm
Pfizer
Mylan
M&A
Upjohn
innovation
How $2.8B Genomic Health deal catapults Exact beyond Cologuard
BioCentury
Mon, 07/29/19 - 11:21 pm
EXACT Sciences
M&A
Genomic Health
Cologuard
cancer
diagnostics
What The Pfizer-Mylan Deal Means For Pharma
Forbes
Mon, 07/29/19 - 11:17 pm
Pfizer
Mylan
M&A
Mylan CEO Heather Bresch to retire after deal to merge with Pfizer's Upjohn closes
Marketwatch
Mon, 07/29/19 - 09:48 am
Mylan
Pfizer
M&A
Pharma CEOs
Heather Bresch
Exact Sciences Buying Genomic Health in $2.8B Cancer Diagnostics Deal
Xconomy
Mon, 07/29/19 - 09:28 am
EXACT Sciences
M&A
Genomic Health
diagostics
Pfizer and Mylan: Is Mega-Merger on the Horizon?
Market Realist
Mon, 07/29/19 - 09:23 am
Pfizer
off-patent
Mylan
Upjohn
M&A
Pfizer in talks to merge off-patent drugs business with Mylan -source
Yahoo/Reuters
Sat, 07/27/19 - 02:13 pm
Pfizer
Mylan
M&A
Bristol's Celgene buyout 'more important' given drug pricing pressure, CEO says
Fierce Pharma
Thu, 07/25/19 - 10:38 pm
Bristol-Myers Squibb
Celgene
M&A
drug pricing
Giovanni Caforio
Medtech's Biggest Deals in 2019 ... So Far
Medical Devices and Diagnostics Industry
Thu, 07/25/19 - 07:20 pm
devices
M&A
Hill-Rom
Voalte
Abbott Laboratories
Cephea Valve Technologies
ZOLL Medical
TherOx
Stryker
Arrinex
Medtronic
Epix Therapeutics
Guardant Health
Bellwether Bio
Titan Spine
Bosotn Scientific
Vertiflex
Edward Lifesciences
CAS Medical Systems
Fresenius
NxStage
JNJ
Auris Health
Among recent megamergers only AbbVie-Allergan looks like a winner: analyst
Fierce Pharma
Wed, 07/24/19 - 10:08 pm
AbbVie
Allergan
M&A
diversification
As Takeda absorbs Shire’s R&D ops, the focus is on replacing a centralized command model with a ‘light touch’ in a restructured global organization
Endpoints
Wed, 07/24/19 - 10:39 am
Takeda
Shire
R&D
restructuring
M&A
Ligand acquires Ab Initio Biotherapeutics, an antigen-discovery company
Pharmaceutical Business Review
Wed, 07/24/19 - 10:20 am
Ligand Pharmaceuticals
Ab Initio Biotherapeutics
M&A

Pages